J. Jeff Schwegman, Ph.D. is the founder and chief executive officer of AB BioTechnologies, where he manages the day to day operations of the company.
Dr. Schwegman received his BS in Biochemistry from Indiana University in 1992 and began working at Cook Imaging in Bloomington, Indiana, where he gained experience in analytical, formulation, and process development. In 1999, he began graduate study in the Department of Industrial and Physical Pharmacy at Purdue University under the direction of Dr. Steve Nail, where his focus of research involved studying changes in the physical structure of biological molecules during lyophilization. Dr. Schwegman received his Ph.D. from Purdue University in 2003 and returned to Bloomington, where he worked at Baxter Pharmaceutical Solutions as a Research Scientist in the Pharmaceutical Development group.
He specializes in speaking and consulting in parenteral pre-formulation, formulation, analytical, and lyophilization of both small molecules and large biomolecules.
In November 2005, he left Baxter and formed a life science company that specialized in developing new formulations and manufacturing processes for parenteral products. In February 2008, he formed AB Biotechnologies.
